Skip to main content
Loading

Rakuten Medical, Inc.

October 18, 2023
Franciscan C
Oncology
Rakuten Medical is a private biotechnology firm that is developing cancer therapies with the ability to target cancer cells and induce immunogenic cell death, using a photoimmunotherapy platform with a lead program that received approval in Japan in 2020 and recently showed promising early results in combination with anti-PD-1 therapy in patients with locoregional and/or metastatic HNSCC.
Speakers
Abhijit Bhatia, Chief Operating Officer - Rakuten Medical, Inc.